Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 28,628 | 231 | 30,925 | 20,063 | 0 |
| Gross Profit | 28,628 | 231 | 30,925 | 20,063 | N/A |
| Operating Expenses | 93,144 | 80,752 | 73,194 | 57,960 | 32,666 |
| Operating Income | -64,516 | -80,521 | -42,269 | -37,897 | -32,666 |
| Interest Expense | 598 | 169 | 0 | 0 | 0 |
| Other Income | 269 | 2,812 | 2,546 | 940 | -4,511 |
| Pre-tax Income | -64,845 | -77,878 | -39,723 | -36,957 | -37,177 |
| Income Tax | 1,305 | -691 | -799 | N/A | N/A |
| Net Income Continuous | -66,150 | -77,187 | -38,924 | -36,957 | -37,177 |
| Net Income | $-66,150 | $-77,187 | $-38,924 | $-36,957 | $-37,177 |
| EPS Basic Total Ops | -1.92 | -2.98 | -1.74 | -2.09 | -5.80 |
| EPS Basic Continuous Ops | -1.92 | -2.98 | -1.74 | -2.09 | -5.72 |
| EPS Diluted Total Ops | -1.92 | -2.98 | -1.74 | -2.09 | -5.80 |
| EPS Diluted Continuous Ops | -1.92 | -2.98 | -1.74 | -2.09 | -5.72 |
| EPS Diluted Before Non-Recurring Items | -1.92 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-61,756 | $-78,591 | $-41,536 | $-36,804 | $-32,232 |